Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer–Specific Mortality Among US Women | Zendy

Kent Hoskins | Zendy; Oana Danciu | Zendy; Naomi Y. Ko | Zendy; Gregory S. Calip | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer–Specific Mortality Among US Women

Author(s) -

Kent Hoskins,

Oana Danciu,

Naomi Y. Ko,

Gregory S. Calip

Publication year - 2021

Publication title -

jama oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 8.846

H-Index - 99

eISSN - 2374-2445

pISSN - 2374-2437

DOI - 10.1001/jamaoncol.2020.7320

Subject(s) - medicine , breast cancer , oncology , cancer , retrospective cohort study , population , cohort , hormone therapy , gynecology , ethnic group , environmental health , sociology , anthropology

Given the widespread use of the 21-gene recurrence score for identifying candidates for adjuvant chemotherapy, it is important to examine the performance of the Oncotype DX Breast Recurrence Score test in diverse patient populations to validate this approach for tailoring treatment in women in racial/ethnic minority groups.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research